S sclerosis (SSc) is characterized by vascular endothelial stress test. sICAM-1 levels increased significantly following VO in SSc patients compared to abnormalities such as Raynaud’s phenomenon, telangiectasia, and thickening/fibrosis of the skin and visceral controls, and this change correlated inversely with skin score (Fig. 1). Levels of sE-selectin were not signifiorgans [1]. SSc may also be associated with peripheral large vessel arterial occlusion [2]. The mechanisms of cantly different in SSc patients compared to controls before or after VO. vascular damage are unclear, but may include endothelial cell (EC) dysfunction. Raised levels of factor VIII SSc is associated with abnormalities of small and large blood vessels [3]. ICAM-1 is an important molecvon Willebrand factor antigen (vWF ) are found in SSc patients, indicating possible EC damage/activation [3]. ule for WBC–EC interaction, an initiating event in the development of inflammation. ICAM-1 is expressed White blood cell ( WBC) activation is also found in SSc [4], suggesting that WBC–EC interaction may be constitutively on EC; however, expression may be induced on a variety of cells by cytokines, nitric oxide an important mechanism of damage. Soluble cell adhesion molecule (sCAM) levels have been measured in and other molecules. A previous study examining sCAM levels in SSc longitudinally over 28–72 months inflammatory diseases including SSc [5] and soluble intercellular adhesion molecule 1 (sICAM-1) levels showed that sE-selectin and sVCAM-1 may act as potential surrogate markers of disease progression [5]. may predict myocardial events in apparently healthy individuals [6 ]. sCAM levels were measured at one In another report, low levels of sCAM were associated with histological evidence of skin sclerosis, but this time point in these studies, although measures were repeated longitudinally in one study. Venous occlusion study did not examine clinical skin score [10]. While CAMs may be raised in a variety of vasculopathies [5, (VO) induces hypoxaemia, which in experimental models increases EC CAM expression in postcapillary 6 ], the function and kinetics of the soluble form are not fully understood; however, single measurements venules probably via cytokine and pro-inflammatory molecule production [7]. We report sCAM levels preare unlikely to reflect disease activity accurately. VO is a hypoxic stress proven to increase CAM expression and post-VO, as a dynamic measure of EC reactivity, in relation to clinical skin score in SSc. on EC in experimental conditions. This is the first time a ‘stress test’ has been SSc patients (ARA classification [8]) and healthy volunteer subjects, matched for age and sex, attended employed in vivo to examine sCAM in a controlled study of SSc patients and normal subjects revealing under standardized conditions. Patients underwent a full assessment with history and clinical examination, an inverse correlation of sICAM-1 change with clinical skin score. This may suggest maximal expresincluding skin score [9]. Briefly, a score of 0 (normal )–3 (thickened, unable to pinch) is assigned sion and shedding of ICAM-1 by activated EC, although other cells do express this CAM in inflamat 17 sites over the trunk, face and limbs to calculate a cumulative score (maximum= 51). Pre-VO blood matory disease. Higher levels of sICAM-1 post-VO was obtained from the antecubital fossa vein without a tourniquet. A sphygmomanometer cuff was inflated to 90 mmHg, on the opposite arm, for 10 min and post-VO blood was sampled prior to releasing the cuff. Serum was prepared and stored at −70°C until sCAM (ng/ml ) was measured in serum (ELISA kits, R&D Systems, UK ). Statistical analysis included the Mann–Whitney U and Spearman rank correlation tests. This study examined the change in sCAM levels (sICAM-1 and sE-selectin) in SSc patients, before and after a hypoxic stimulus (VO), providing a dynamic
Read full abstract